• A novel <em>FGF23</em> mutation in hyperphosphatemic familial tumoral calcinosis and its deleterious effect on protein O-glycosylation
• A probable case of infantile cortical hyperostosis in 2nd-4th centuries AD Romania
• A Rare Case of Infantile Cortical Hyperostosis (ICH) of the Bilateral Tibia or Caffey Disease
• A Rare Case of Lethal Prenatal-Onset Infantile Cortical Hyperostosis
• Added value of newer optical coherence tomography technologies in hyperphosphatemic familial tumoural calcinosis
• Adult Chinese twins with Kenny-Caffey syndrome type 2: A potential age-dependent phenotype and review of literature
• Al-Gazali Skeletal Dysplasia Constitutes the Lethal End of ADAMTSL2-Related Disorders
• An Efficient Method for Screening Rice Breeding Lines Against Races of <em>Magnaporthe oryzae</em>
• An efficient method for screening rice breeding lines against races of Magnaporthe oryzae
• Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies
• Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis
• Birth Order and Maternal Age for Reported Cases of Severe Prenatal Cortical Hyperostosis (Caffey-Silverman Disease)
• Caffey Disease in Infancy: A diagnostic dilemma for primary care physicians
• Caffey disease is associated with distinct arginine to cysteine substitutions in the proalpha1(I) chain of type I procollagen
• Caffey disease is associated with distinct arginine to cysteine substitutions in the proα1(I) chain of type I procollagen
• Caffey's disease in disguise: a child abuse mimic
• Caffey's Disease of the Scapula: A Case Report
• Caffey's Disease Sans Mandibular and Clavicular Involvement: A Rare Case Report
• Canine models of human rare disorders
• Case Report of Worth Syndrome and Chiari I Malformation: Unusual Association and Surgical Treatment
• Case report: Late middle-aged features of <em>FAM111A</em> variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-up
• Case report: Late middle-aged features of FAM111A variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-up
• Clinical and genetic features of Kenny-Caffey syndrome type 2 with multiple electrolyte disturbances: A case report
• Clinical and Molecular Diagnosis of Osteocraniostenosis in Fetuses and Newborns: Prenatal Ultrasound, Clinical, Radiological and Pathological Features
• Compound Heterozygous Variants in <em>FAM111A</em> Cause Autosomal Recessive Kenny-Caffey Syndrome Type 2
• Compound Heterozygous Variants in FAM111A Cause Autosomal Recessive Kenny-Caffey Syndrome Type 2
• Congenital cortical hyperostosis: a rare cause of inconsolable crying in a baby. Clinical case report
• Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23
• Contribution of DNA Replication to the FAM111A-Mediated Simian Virus 40 Host Range Phenotype
• Cortical Hyperostosis after Long-Lasting Prostaglandin E1 Treatment in a Newborn with Complex Congenital Heart Disease
• Cortical hyperostosis, rare adverse effect of prostaglandin
• Defective O-glycosylation of novel FGF23 mutations in a Chinese family with hyperphosphatemic familial tumoral calcinosis
• Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation
• Differential Diagnosis between Child Abuse and Infantile Cortical Hyperostosis: A Case Report and Literature Review
• Disruption of the c-terminal serine protease domain of Fam111a does not alter calcium homeostasis in mice
• Evaluation of Commercial Next-Generation Sequencing Bioinformatics Software Solutions
• Expanding the Phenotypic Spectrum of Kenny-Caffey Syndrome
• Expanding the phenotypic spectrum of Kenny-Caffey syndrome: a case series and systematic literature review
• Expansion of Phenotypic Spectrum in Hyperphosphatemic Familial Tumoral Calcinosis
• FAM111 protease activity undermines cellular fitness and is amplified by gain-of-function mutations in human disease
• FAM111A induces nuclear dysfunction in disease and viral restriction
• FAM111A is dispensable for electrolyte homeostasis in mice
• FAM111A regulates replication origin activation and cell fitness
• Fetuin-A deficiency is associated with infantile cortical hyperostosis (Caffey disease)
• FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with α-Klotho
• Framework for a Community Health Observing System for the Gulf of Mexico Region: Preparing for Future Disasters
• Further delineation of phenotype and genotype of Kenny-Caffey syndrome type 2 (phenotype and genotype of KCS type 2)
• Garre's Osteomyelitis of the Mandible Caused by Infected Tooth
• Genetic Characterization of the Partial Disease Resistance of Rice to Bacterial Panicle Blight and Sheath Blight by Combined QTL Linkage and QTL-seq Analyses
• Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease
• Hyperphosphataemic tumoral calcinosis
• Hyperphosphatemic familial tumoral calcinosis caused by a novel variant in the GALNT3 gene
• Hyperphosphatemic familial tumoral calcinosis in a dancer
• Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in <em>GALNT3</em> Gene: Experience from Southern Turkey
• Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature
• Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?
• Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
• Hypertrophic osteopathy in a cat with cardiac interventricular septal defect
• Identification and mapping of a novel resistance gene to the rice pathogen, Cercospora janseana
• INFANT WITH MANDIBULAR SWELLING: A CASE OF INFANTILE CORTICAL HYPEROSTOSIS
• Infantile Cortical Hyperostosis
• Infantile Cortical Hyperostosis
• Infantile cortical hyperostosis manifesting as congenital unilateral proptosis
• Infantile Cortical Hyperostosis of Scapula Presenting as Pseudoparalysis in an Infant
• Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts
• Jaw Hyperostosis in Infants: Keep in Mind Caffey's Disease
• John P. Caffey, 1895-1978
• Kenny-Caffey syndrome type 2
• Kenny-Caffey Syndrome Type 2: A Unique Presentation and Craniofacial Analysis
• Krüppel-like factor 3 inhibition by mutated lncRNA <em>Reg1cp</em> results in human high bone mass syndrome
• Lenz majewskihyperostotic dwarfism: A Pakistani patient with atypical features
• Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome
• LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature
• Molecular mechanisms and clinical manifestations of rare genetic disorders associated with type I collagen
• Monostotic Scapular Caffey Disease: A Case Report With MRI Correlate
• Mother and daughter with Kenny-Caffey syndrome: the adult phenotype
• Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report
• Oral rehabilitation of a patient with Kenny-Caffey syndrome using telescopic overdenture
• Overlapping phenotype comprising Kenny-Caffey type 2 and Sanjad-Sakati syndromes: The first case report
• Polyostotic cortical hyperostosis in an 8-week-old cat with a 3-year follow-up
• Primary hyperphosphatemic tumoral calcinosis: a case report
• PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1-34
• Radiographic overlap of recurrent Caffey disease and chronic recurrent multifocal osteomyelitis (CRMO) with considerations of molecular origins
• Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis
• Recurrence of tumoral calcinosis: a case report
• Report of a novel variant in the FAM111A gene in a fetus with multiple anomalies including gracile bones, hypoplastic spleen, and hypomineralized skull
• Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis
• The IFITM5 Ser40Leu variant can manifest as prenatal Caffey disease
• The rice blast resistance gene Ptr encodes an atypical protein required for broad-spectrum disease resistance
• The role of calcium-sensing receptor signaling in regulating transepithelial calcium transport
• The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in <em>FGF23</em>
• Therapeutic success of sodium thiosulfate in treating cutaneous calciphylaxis in a patient with hyperphosphataemic familial tumoral calcinosis
• Unravelling the Intricate Roles of FAM111A and FAM111B: From Protease-Mediated Cellular Processes to Disease Implications
• Unusual findings on infantile cortical hyperostosis: A case report
• Use of Teriparatide in Hyperphosphatemic Familial Tumor Calcinosis: Evaluating the Interaction Between FGF23 and PTH on the Phosphaturic Effect
• Whole Genome Sequencing Indicates Heterogeneity of Hyperostotic Disorders in Dogs
• Wnt/beta-catenin Signaling Controls Maxillofacial Hyperostosis
• Wnt/β-catenin Signaling Controls Maxillofacial Hyperostosis
• Worth syndrome "mandibular osteosclerosis" as an incidental finding: a report of 2 cases
• Worth Syndrome-Patient Report, Diagnostic Work-Up, and Surgical Management of a Rare Craniofacial Entity